Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: ACLX) | Delayed: 115.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.07 | 52 Week High | $ | |||
| Open | $115.07 | 52 Week Low | $ | |||
| Day High | $115.07 | P/E | N/A | |||
| Day Low | $115.07 | EPS | $ | |||
| Volume | 149 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.43 -0.74 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.17 | 52 Week High | $108.63 | |||
| Open | $151.84 | 52 Week Low | $71.39 | |||
| Day High | $152.26 | P/E | 83.11 | |||
| Day Low | $149.80 | EPS | $1.81 | |||
| Volume | 6,255,479 | |||||
